10x Genomics (TXG) Long-Term Debt Repayments (2020)

10x Genomics' (TXG) quarterly Long-Term Debt Repayments came in at $31.3 million in Q1 2020.

10x Genomics (TXG) Long-Term Debt Repayments (2020) Analysis & Trends

10x Genomics has disclosed Long-Term Debt Repayments across 1 years of filings, most recently posting $31.3 million for Q1 2020.

  • Long-Term Debt Repayments for Q1 2020 came in at $31.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $31.3 million (changed N/A YoY), and the FY2020 annual result was $31.3 million, changed N/A from the prior year.
  • Long-Term Debt Repayments came in at $31.3 million for Q1 2020 at 10x Genomics.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $31.3 million in Q1 2020 to a low of $31.3 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn -
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn 12.35 Mn
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn 15.00 Mn
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn -
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn -
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn -
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn 23.55 Mn
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn -
10 Teladoc Health 1.31 Bn 562.23 Mn 562.57 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2020 31.26 Mn
Mar 31, 2020 31.26 Mn